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EMPLOYMENT OPPORTUNITIES
Faculty in Statistical or Quantitative Genetics.—The
Department of Preventive Medicine and Biometrics and
the Human Medical Genetics Program at the University
of Colorado Health Sciences Center are seeking a faculty
member, at the Assistant or Associate Professor level
(tenure eligible), with expertise in statistical or quanti-
tative genetics. A Ph.D. in genetics, statistical genetics,
or a related field is required. The ideal candidate will
conduct independent research in statistical/quantitative
genetics, especially in the development and application
of novel methods for the analysis of complex diseases;
work with existing data from family studies of type 1
and type 2 diabetes, other autoimmune diseases, and
cancer; teach at the master’s and doctoral level; and
collaborate with investigators in biomedical and genetic
epidemiological research. Send a cover letter, a curric-
ulum vitae, a statement of research interests, and the
names of three references to Statistical/Quantitative Ge-
neticist Search Committee, Jill M. Norris,M.P.H., Ph.D.,
Department of Preventive Medicine and Biometrics, Box
C245, University of Colorado Health Sciences Center,
4200 East Ninth Avenue, Denver, CO 80262 (e-mail:
jill.norris@uchsc.edu). The University of Colorado
Health Sciences Center is committed to equal oppor-
tunity and affirmative action.
Co-Director, Clinical Cytogenetics.—Laboratory Cor-
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poration of America’s Department of Diagnostic
Genetics is seeking applicants for the position of Co-
Director, to join a team of four Co-Directors. The lab-
oratory is located in the Center for Molecular Biology
and Pathology in Research Triangle Park, NC. This high-
volume laboratory processes an extensive cross-section
of cytogenetics, molecular cytogenetics, and adjunctive
molecular tests. The facility performs all related ancillary
tests in contiguous laboratories. These include immu-
nocytometry, immunohistochemistry, identity testing,
biochemical genetics, and molecular genetics. Candi-
dates should have a Ph.D. and/or an M.D. and should
be board-certified by ABMG in clinical cytogenetics. Sal-
ary will be commensurate with experience. Duties will
include preparing and reviewing cytogenetics case re-
ports, overseeing personnel, test-protocol development/
refining, and training of sales specialists. Please send a
curriculum vitae and a list of three references to Dr. Peter
Papenhausen, National Director of Genetics, LabCorp,
1912 Alexander Drive, Research Triangle Park, NC
27709 (e-mail: papenhp@labcorp.com). EOE/M/F/D/V.
Faculty Position in Clinical Genetics.—The Division of
Medical Genetics, Department of Pediatrics, Children’s
Specialty Group, PLLC, at the Children’s Hospital of
The King’s Daughters, Eastern Virginia Medical School,
seeks a faculty member at the assistant- or associate-
professor level (tenure eligible) with expertise in clinical
genetics and dysmorphology. Board certification in pe-
diatrics and eligibility in medical genetics is required for
practice in a rapidly expanding clinical genetics service.
Activities will include management of children and
adults with genetic and metabolic disorders and teaching
of genetic counselors, nurses, medical students, and res-
idents. Opportunities exist for participation in clinical
research studies and collaboration with investigators at
the Center for Pediatric Research. Please send a curric-
ulum vitae and a statement of clinical and research in-
terests, together with the names of three references, to
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Virginia K. Proud, MD, Director, Division of Medical
Genetics, Children’s Specialty Group, PLLC, The Chil-
dren’s Hospital of The King’s Daughters, 601 Children’s
Lane, Norfolk VA, 23507-1921 (e-mail: vproud@
chkd.com). The Children’s Specialty Group, PLLC, is
committed to equal opportunity and affirmative action.
Residency in Medical Genetics.—The Center for Mo-
lecular Medicine and Genetics at Wayne State University
School of Medicine has an RRC-accredited residency
position in medical genetics available beginning in July
2000. The program offers a comprehensive academic
medical-genetics program, with opportunities in pedi-
atric, adult, and reproductive genetics services. The large
and diverse patient population of the Detroit Medical
Center–affiliated hospitals provides excellent opportu-
nities for clinical training and research. In addition to
the Medical Genetics Residency Program, the Center
provides graduate and post-doctoral research training
and ABMG-accredited training programs in clinical cy-
togenetics, clinical biochemical genetics, and clinicalmo-
lecular genetics. The fellowship is tailored to the interests
of each fellow, with opportunities for completion of
Board requirements in more than one genetics sub-
specialty area. Financial support is institutional and is
dependent upon the individual’s level of training. Ad-
dress inquiries to Gerald L. Feldman, M.D., Ph.D.,
F.A.C.M.G., Medical Genetics ProgramDirector andDi-
rector of Clinical Genetics Services, Center forMolecular
Medicine and Genetics, Wayne State University School
of Medicine, 540 E. Canfield, 3216 Scott Hall, Detroit
MI 48201; phone: (313) 577-6298; fax: (313) 577-
5218; e-mail: glfeldman@pol.net. Wayne State Univer-
sity is an equal opportunity/affirmative action employer.
Postdoctoral Position.—The focus of this position is the
development of adeno-associated virus (AAV) vectors for
treatment of glycogen storage disease type II (Pompe
disease) in animal models for Pompe disease. AAV is a
nonpathogenic parvovirus, and AAV vectors mediate
long-term transduction of cells in vitro and in vivo. AAV
vectors have been shown to produce therapeutically rel-
evant levels of protein in mouse liver and muscle. We
will develop AAV vectors for delivery of a-glucosidase
to muscle and liver in the mouse and quail models for
Pompe disease. Therapeutic expression of a-glucosidase
in Pompe disease would provide an innovative therapy
for this lethal disorder. This project will require strong
molecular biology skills and experience working with
mouse models, and a background in virology and human
genetics is preferred. Previous experience with viral vec-
tors, especially adenovirus and AAV vectors, will be
viewed as a strength. A Ph.D., M.D./Ph.D., or D.V.M./
Ph.D. is a required credential. Please send a letter of
interest and three letters of reference to Dwight D. Koe-
berl, M.D., Ph.D., Assistant Professor; Division of Med-
ical Genetics, Bell Building, Room 237, DUMC 3528,
Durham, NC 27710. E-mail: koebe001@mc.duke.edu
FELLOWSHIP
Research Fellowship.—A postdoctoral (Ph.D. and/or
M.D.) fellowship position is available in the Laboratory
of Molecular Genetics, National Institute on Deafness
and Other Communication Disorders, National Insti-
tutes of Health. Candidates should have !5 years of
postdoctoral experience and an interest in the molecular
genetic analysis of hereditary deafness, auditory func-
tion, and inner-ear development. Experience in molec-
ular biological techniques is desirable. The Laboratory
of Molecular Genetics is housed in a spacious new build-
ing with well-equipped laboratories and many collegial
scientists. Recent (1998–1999) publications include Nat
Genet 23:413–419, Nat Genet 21:347–349, and Am J
Hum Genet 62:816–823. By May 15, 2000, please sub-
mit a curriculum vitae with bibliography; copies of re-
cent publications; and the names, addresses, and tele-
phone numbers of three references to Andrew Griffith,
M.D., Ph.D., Laboratory of Molecular Genetics,
NIDCD/NIH, 5 Research Court, Room 2A02, Rock-
ville, MD 20850; telephone: (301) 496-1960; fax (301)
480-8019; e-mail griffita@nidcd.nih.gov. NIH is an
equal opportunity employer.
CELL REPOSITORIES
New Resources for Aging Research.—New tools are
now available for understanding the biomolecularmech-
anisms that underlie senescence: a series of panels have
been assembled from the NIA Aging Cell Repository.
These include an aging-syndrome panel, two Alzheimer-
disease panels, and an aged-sib-pair panel. The aging-
syndrome panel includes 25 samples from four aging
syndromes: progeria (7), Werner syndrome (11), Cock-
ayne syndrome (4), and Rothmund-Thomson syndrome
(3). Each Alzheimer-disease panel is composed of 10
individuals affected with familial Alzheimer disease, se-
lected on the basis of whether the onset of the disease
was early (!!50 years of age) or late (160 years of age).
The samples in these two panels have been genotyped
for the apolipoprotein E alleles epsilon 2, 3, and 4. The
aged-sib-pair panel consists of 10 sib pairs with ages
185 years. These resources have been compiled to screen
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for existing age-related markers as well as for the dis-
covery of new genetic factors affecting aging. These pan-
els are available as cell cultures or as DNA. Additional
information can be obtained at http://locus.umdnj.edu/
nia or from the NIA Aging Cell Repository, Coriell Cell
Repositories, 401 Haddon Avenue, Camden, NJ 08103;
telephone: (800) 752-3805 within the United States,
(856) 757-4848 from other countries; fax: (856) 757-
9737; e-mail: ccr@arginine.umdnj.edu
World Wide Web Catalog.—To ensure that investigators
have access to the most up-to-date information and com-
plete listings of cell cultures and DNA samples, the
NIGMS Human Genetic Cell Repository has a World
Wide Web catalog (http://locus.umdnj.edu/nigms). The
repository has human-cell cultures available in the fol-
lowing categories: inherited metabolic disorders, bio-
chemically mutant cell cultures with characterized mu-
tations, well-characterized chromosomally aberrant cell
cultures, CEPH Reference Families, a human-diversity
collection, and human/rodent somatic cell hybrid map-
ping panels. Menus are provided to allow users to search
for cell cultures or DNA samples in a variety of ways,
including repository number, MIM number, gene name,
disease description, chromosome abnormality, and chro-
mosome number. Chromosome ideograms are provided
for human/rodent somatic cell hybrids. Questions and
comments about the catalog should be directed toCoriell
Cell Repositories, Coriell Institute forMedical Research,
401 Haddon Avenue, Camden, NJ 08103; telephone:
(800) 752-3805 in the United States or (856) 757-4848
from other countries; fax: (856) 757-9737; e-mail: ccr@
arginine.umdnj.edu
CALL FOR PROPOSALS
Chromosome 16 Disorders.—The Disorders of Chro-
mosome 16 Foundation (DOC16) announces the avail-
ability of $30,000 (total) to be awarded in a grant(s) to
foster research on chromosome 16 anomalies, including
(but not limited to) mosaic trisomy 16, partial trisomy
16, and structural abnormalities of chromosome 16. Re-
search can also involve diagnosis, mechanism, or clinical
significance of other chromosome abnormalities, but this
should have significance for disorders of chromosome
16. DOC16 will be flexible regarding the number of
proposals awarded and the amount of funding for each.
Grants are for a 1-year period, and a progress report is
expected at the end of the granting period. Applicants
should include a one-page summary abstract of pro-
posed research. The main body of the proposal should
not exceed six pages and should include the following:
identification of the primary investigator, a summary of
background, a hypothesis, a description of method, the
significance of proposed research, and a time frame for
completion. A one-page budget summary and justifica-
tion should also be included. No indirect costs will be
allowed. A curriculum vitae of the principal investiga-
tor(s) should also be included, along with letters of sup-
port/collaboration where necessary. Proposals dealing
with human or animal subjects must conform to the
usual review by an institutional review board (IRB); a
copy of approval must be provided before funding can
be released. Deadline for receipt is April 1, 2000. In-
vestigators should submit proposals and questions to
Karen Lange, M.S., President, Disorders of Chromo-
some 16 Foundation, 331 Haddon Circle, Vernon Hills,
IL 60061. E-mail: wlango@aol.com; telephone: (847)
816-0627; fax: (847) 367-4031. DOC16’s Medical Ad-
visory Board will review proposals. Notice of award is
expected by June 1, 2000.
CALL FOR PATIENTS
X-linked Neonatal Diabetes Mellitus, Polyendocrino-
pathy, and Fatal Infection (MIM 304930) or X-linked
Diabetes Mellitus, Insulin-dependent, with Fatal Secre-
tory Diarrhea (MIM 304790).—Patients with features
consistent with or overlapping these usually fatal dis-
orders of immune dysregulation affecting boys are
sought for analysis of candidate genes and, if possible,
linkage mapping. Sporadic cases qualify, and stored
DNA samples from deceased patients are acceptable. For
further information and informed consent forms, please
contact Robert S. Wildin, M.D., Assistant Professor of
Medical Genetics, Department of Molecular and Med-
ical Genetics, L103A, Oregon Health Sciences Univer-
sity, 3181 Southwest Sam Jackson Park Road, Portland,
OR 97201-3098; telephone: (503) 494-4416; fax: (503)
494-4411; e-mail: wildinr@ohsu.edu. This activity is
approved by the OHSU Institutional Review Board
(#5325).
RESEARCH AWARD
Support for Research on Angelman Syndrome.—The
Angelman Syndrome Foundation announces the avail-
ability of up to $100,000 to be awarded in support of
research on Angelman syndrome (AS). All areas of
biomedical and behavioral research involving AS will be
considered. The Foundation will be flexible regarding
the number of awards made and the amount of funding
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for each. The deadline for receipt of applications is
March 1, 2000. For information about application
guidelines, contact Professor Daniel F. Harvey, Chair,
ASF Scientific Advisory Committee, Department of
Chemistry and Biochemistry, University of California,
San Diego, La Jolla, CA 92093-0358; telephone: (858)
534-0388; e-mail: dharvey@ucsd.edu
COURSE
26th Advanced Course: “Human Genome Analysis: Ge-
netic Analysis of Multifactorial Diseases.”—Intensive
computer-based course for scientists involved in genetic
analysis of multifactorial traits, to be held July 26–
August 1, 2000, at theWellcome Trust GenomeCampus,
Hinxton, Cambridge, United Kingdom. Organized by
Daniel Weeks and Mark Lathrop. Confirmed speakers:
Nancy Cox (Chicago), Eleanor Feingold (Pittsburgh),
Bill Forrest (Pittsburgh), Pak Sham (London), Richard
Spielman (Philadelphia), and Ken Weiss (State College,
PA). Topics to be covered include “Qualitative Traits:
Sib-Pair Methods,” “Qualitative Traits: Affected-Rela-
tiveMethods,” “Quantitative Traits: Sib-PairMethods,”
“Markov Chain Monte Carlo Approaches,” and “Link-
age Disequilibrium: Testing for Association.” Teaching
will take the form of lectures by invited speakers, in-
formal tutorials, hands-on computer sessions, and anal-
ysis of disease family data sets. There will also be an
opportunity to analyze and discuss participants’ own
data sets. Applicants (postdoctoral or equivalent) should
send a hard copy of their full curriculum vitae; a 300-
word outline of their current and ongoing research plans,
indicating the relevance of the course; and documenta-
tion verifying active involvement in a linkage- or family-
based association study (animal/human), to Dr. Pelin
Faik, Advanced Courses Manager, Wellcome Trust Ad-
vanced Courses, The Wellcome Trust, 183 Euston Road,
London NW1 2BE; fax 44 (0) 20 7611 8688; e-mail:
advancedcourses@wellcome.ac.uk. Open to scientists
worldwide, the course is strictly residential. Course costs
are subsidized by the Wellcome Trust, but there is a
charge of £450 toward board and lodging. Further
information is available on our Web site (http://www
.wellcome.ac.uk/advancedcourses/). Closing date for
applications is April 19, 2000.
DATABASE SOFTWARE
Familial Cancer Database.—The first official version of
the Familial Cancer Database (FaCD), written by Dutch
clinical geneticist Rolf Sijmons and pathologist Gerard
Burger, has now been released, in support of the UICC
Familial Cancer and Prevention Project. FaCD is a stand-
alone computer program that may help clinicians and
genetic counselors in diagnosing hereditary cancer. It
tries to match the phenotype of a patient or family with
cancer with the profiles of the 1300 cancer-associated
familial and hereditary disorders stored in its database.
FaCD is aimed at health care professionals with at least
a basic knowledge of clinical cancer genetics. The soft-
ware can be downloaded, after free registration, at the
FaCD Web site (http://facd.uicc.org). The authors can
be contacted via e-mail (facd@medgen.azg.nl).
